News from the healthcare data industry
28-Jan-2022 By Jenni Spinner A representative from IQVIA discusses the particulars of the US agency’s new draft document and shares what it might mean for clinical trial data evaluation. Source: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/01/28/NEW-FDA-DRAFT-GUIDANCE-DOCUMENT-GETS-REAL-ABOUT-RWD-USE
Zachary BrennanSenior Editor, Endpoint News Back in late September, the FDA released a long-awaited guidance on how the industry might use electronic health records (EHRs) or medical claims data in clinical studies to support a regulatory decision for effectiveness or safety. FDA+ guidance roundup: Benefit-risk assessments, RWE to support regulatory…
Real-world evidence-based software product empowers life sciences companies to improve the recruitment of diverse and underrepresented patient populations January 26, 2022 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading platform analytics company delivering real-world insights to healthcare and life sciences organizations, announced the launch of Clarify Trials today. This…
Cambridge, MA, January 27, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Shogo Wakabayashi has joined the company as Country Manager for Japan. Wakabayashi, a business leader with extensive global experience bringing new offerings to market, will…
January 26, 2022 $18.5 million in funding from the Cancer Moonshot will help researchers at USC Norris Comprehensive Cancer Center close the gap in our understanding of colorectal cancer in Hispanic patients By Sarah Nightingale Medical trials lead to important innovations that save lives. But some racial and ethnic groups…
LONDON, Jan. 26, 2022 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report from the company’s Institute for Scientific Information™ which proposes a new method for analyzing the credit authors of academic papers receive via citations. Across the research landscape, receipt…
26th January 2022 Sensyne Health plc, the UK clinical AI company, says it has successfully completed the financing announced on 14 January 2022. This follows warnings from the board that without an emergency cash injection, the company would be unable trade beyond early February 2022. The financing comprises up to…
World’s largest repository of deidentified data for genetics research is providing scientists access to NVIDIA Clara Parabricks to fuel accelerated genomics and drug discovery. January 26, 2022 by CRAIG RHODES UK Biobank is broadening scientists’ access to high-quality genomic data and analysis by making its massive dataset available in the cloud alongside…
The dermatology community remains concerned about the risk of COVID-19 in individuals with atopic dermatitis (AD). Using Symphony Health-derived data from the COVID-19 Research Database,1Â we aimed to assess the risk of contracting COVID-19 in adults with AD while controlling for demographic factors and comorbidities known or speculated to be COVID-19…
Atlas, Carta Healthcare’s AI-assisted data abstraction solution, provides seamless, end-to-end submissions to the ACC’s AFib Ablation clinical data registryJanuary 26, 2022 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Carta Healthcare, provider of solutions for common healthcare data challenges through a combination of people, processes, and artificial intelligence (AI)–powered technology, today…